Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tyree H Kiser

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Hospital Pharmacy|December 6, 2014
Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?Tyree H Kiser
Hospital Pharmacy|June 13, 2022
Pharmacologic Options for Prevention and Management of Cerebral Vasospasm in Aneurysmal Subarachnoid HemorrhageTyree H Kiser
International Journal of Clinical Medicine|April 15, 2020
Hepatorenal SyndromeTyree H Kiser
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 3, 2024
Bridging the gap: Advocating for the advancement of critical care pharmacists and critical care pharmacy practiceRobert MacLaren, Tyree H Kiser
Advances in Chronic Kidney Disease|August 24, 2010
Systemic anticoagulation considerations in chronic kidney diseaseWilliam E Dager, Tyree H Kiser
Current Fungal Infection Reports|April 15, 2020
Pros and Cons of Extrapolating Animal Data on Antifungal Pharmacodynamics to HumansScott W Mueller, Tyree H Kiser
Pharmacotherapy|June 8, 2013
Correlation of pharmacokinetic/pharmacodynamic-derived predictions of antibiotic efficacy with clinical outcomes in severely ill patients with Pseudomonas aeruginosa pneumoniaDouglas N Fish, Tyree H Kiser
Pharmacotherapy|March 24, 2006
Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunctionTyree H Kiser, Douglas N Fish
Current Opinion in Pulmonary Medicine|January 10, 2015
Severe acute exacerbations of chronic obstructive pulmonary disease: does the dosage of corticosteroids and type of antibiotic matter?Tyree H Kiser, R William Vandivier
Journal of the American College of Clinical Pharmacy : JACCP|August 24, 2023
Continuing excellence in critical care pharmacy practice, education, and advocacyAmy L Dzierba, Tyree H Kiser
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Hospital Pharmacy|December 6, 2014
Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?Tyree H Kiser
Hospital Pharmacy|June 13, 2022
Pharmacologic Options for Prevention and Management of Cerebral Vasospasm in Aneurysmal Subarachnoid HemorrhageTyree H Kiser
International Journal of Clinical Medicine|April 15, 2020
Hepatorenal SyndromeTyree H Kiser
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 3, 2024
Bridging the gap: Advocating for the advancement of critical care pharmacists and critical care pharmacy practiceRobert MacLaren, Tyree H Kiser
Advances in Chronic Kidney Disease|August 24, 2010
Systemic anticoagulation considerations in chronic kidney diseaseWilliam E Dager, Tyree H Kiser
Current Fungal Infection Reports|April 15, 2020
Pros and Cons of Extrapolating Animal Data on Antifungal Pharmacodynamics to HumansScott W Mueller, Tyree H Kiser
Pharmacotherapy|June 8, 2013
Correlation of pharmacokinetic/pharmacodynamic-derived predictions of antibiotic efficacy with clinical outcomes in severely ill patients with Pseudomonas aeruginosa pneumoniaDouglas N Fish, Tyree H Kiser
Pharmacotherapy|March 24, 2006
Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunctionTyree H Kiser, Douglas N Fish
Current Opinion in Pulmonary Medicine|January 10, 2015
Severe acute exacerbations of chronic obstructive pulmonary disease: does the dosage of corticosteroids and type of antibiotic matter?Tyree H Kiser, R William Vandivier
Journal of the American College of Clinical Pharmacy : JACCP|August 24, 2023
Continuing excellence in critical care pharmacy practice, education, and advocacyAmy L Dzierba, Tyree H Kiser
Pageof 13